3H Health Investment
Hong Kong SAR3hhinvestment.com
Overview
3H Health Investment, founded in 2016, is a healthcare venture capital firm based in Hong Kong and Shanghai . It focuses on venture to early-growth investment opportunities in the biotech and medtech sectors in Asia . The firm partners with exceptional scientists and entrepreneurs to drive breakthroughs and help patients with unmet medical needs .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Angitia | Feb 2026 | Series D | Co-investor |
| Timberlyne Therapeutics | Jan 2025 | Series A | Co-investor |
| Angitia | Dec 2024 | Series C | - |
| Angitia | Oct 2023 | Series B Extension | Co-investor |
| Edge Medical Robotics | Nov 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.